Real-time enrollment status for this acute myeloid leukemia clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 9:29 AM UTC
| NCT Number | NCT06484062 |
| Recruiting Status | Recruiting |
| Condition | Acute Myeloid Leukemia |
| Phase | PHASE1 |
| Target Enrollment | 54 participants |
| Active Locations | 22 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | June 11, 2026 (Jun 11, 2026) |
As of August 27, 2026: Clinical trial NCT06484062 is currently recruiting participants. This phase1 study for acute myeloid leukemia is actively seeking new participants at 22 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06484062 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 22 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06484062 was last updated Jun 11, 2026 (June 11, 2026). HelloStudys verifies this status automatically.